Stock CPMD CANNAPHARMARX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials CannaPharmaRX, Inc.

Equities

CPMD

US13765D1090

Pharmaceuticals

Delayed OTC Markets
Other stock markets
 11:16:00 17/04/2024 pm IST 		5-day change 1st Jan Change
0.01 USD -31.03% Intraday chart for CannaPharmaRX, Inc. -.--% +488.24%
14/03 CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product CI
05/03 CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with Ican to Create Distribution Network in the Latin Americas CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 9.878 30.53 45.81 21.89 1.584 2.569
Enterprise Value (EV) 1 9.898 39.27 55.09 31.55 10.58 17.09
P/E ratio -1,491 x -9.87 x -1.92 x -1 x -0.11 x -0.25 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - - -1,93,19,451 x -69,96,849 x -40,45,924 x -34,76,206 x
EV / FCF - - -10,96,22,562 x 44,59,259 x -25,49,745 x 4,45,80,261 x
FCF Yield - - -0% 0% -0% 0%
Price to Book -10.2 x -93 x 10.6 x -2.46 x -0.12 x -0.14 x
Nbr of stocks (in thousands) 17,960 17,961 36,354 44,668 1,22,298 2,56,950
Reference price 2 0.5500 1.700 1.260 0.4900 0.0130 0.0100
Announcement Date 14/09/18 03/04/19 27/05/20 14/04/21 15/04/22 01/09/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA - - -2.851 -4.51 -2.614 -4.917
EBIT 1 -0.006633 -0.5328 -2.98 -4.638 -2.616 -5.212
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -0.006633 -3.094 -20.45 -19.89 -8.832 -8.531
Net income 1 -0.006633 -3.094 -20.45 -19.89 -8.832 -8.531
Net margin - - - - - -
EPS 2 -0.000369 -0.1723 -0.6560 -0.4887 -0.1183 -0.0404
Free Cash Flow - - -0.5025 7.076 -4.148 0.3834
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 14/09/18 03/04/19 27/05/20 14/04/21 15/04/22 01/09/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.02 8.74 9.28 9.67 8.99 14.5
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - - -3.255 x -2.143 x -3.44 x -2.954 x
Free Cash Flow - - -0.5 7.08 -4.15 0.38
ROE (net income / shareholders' equity) 0.69% 495% -895% 1,008% 81.3% 56.4%
ROA (Net income/ Total Assets) - - -14.3% -23.4% -36.9% -118%
Assets 1 - - 143.4 84.96 23.93 7.24
Book Value Per Share 2 -0.0500 -0.0200 0.1200 -0.2000 -0.1100 -0.0700
Cash Flow per Share - 0.0200 0 0.0100 0 0
Capex - - 0.05 - 0.01 0.12
Capex / Sales - - - - - -
Announcement Date 14/09/18 03/04/19 27/05/20 14/04/21 15/04/22 01/09/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CANNAPHARMARX, INC. Stock CannaPharmaRX, Inc.
+488.24% 6.54M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.56% 695B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.70% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.74% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 239B
NOVARTIS AG Stock Novartis AG
+8.78% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 198B
AMGEN INC. Stock Amgen Inc.
+8.78% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CPMD Stock
  4. Financials CannaPharmaRX, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW